Mara Specht

University of Freiburg

Papers

1

Total Citations

4

H-Index

1

About

Mara Specht is a researcher at the forefront of microfluidic technology for clinical diagnostics, with a primary focus on developing automated, high-sensitivity platforms for cancer monitoring. Her most influential work introduces the "MRD disk," a centrifugal microfluidic device that enables automated, multiplexed quantitative PCR (qPCR) for minimal residual disease (MRD) detection. This proof-of-principle study, published in 2020, demonstrates a breakthrough in standardizing repetitive, longitudinal assays that demand exceptional reproducibility and sensitivity—critical for tracking cancer recurrence. While the paper has garnered 4 citations, its impact lies in addressing a key bottleneck in precision oncology: the need for reliable, automated tools to detect residual cancer cells after treatment. Specht’s contributions bridge engineering and clinical application, offering a pathway toward more accessible and consistent MRD monitoring. Her work is particularly notable for its potential to reduce manual error and enhance throughput in high-stakes diagnostic settings, positioning her as an emerging leader in lab-on-a-chip solutions for personalized medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
The MRD disk: automated minimal residual disease monitoring by highly sensitive centrifugal microfluidic multiplex qPCR
4 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: University of Freiburg

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago